MENU
PCR
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

PCR stock forecast, quote, news & analysis

The investment seeks income and capital appreciation... Show more

Category: #Miscellaneous
PCR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PCR with price predictions
Oct 02, 2026

Momentum Indicator for PCR turns negative, indicating new downward trend

PCR saw its Momentum Indicator move below the 0 level on August 27, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator turned negative. In 16 of the 16 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PCR turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In 7 of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

PCR moved below its 50-day moving average on September 03, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PCR crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for PCR entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

PCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC).

Industry description

The investment seeks income and capital appreciation. The fund is an actively managed ETF. The adviser seeks to fulfill both the income and capital appreciation aspects the fund’s investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus any borrowings for investment purposes) in securities included in the VettaFi Private Credit Index and/or through instruments that seek to track the returns of the constituents of the index. The fund is non-diversified.

Market Cap

The average market capitalization across the Simplify VettaFi Private Credit Strategy ETF (PCR) ETF is 152.64B. The market cap for tickers in the group ranges from 658.33M to 13.74B. ARCC holds the highest valuation in this group at 13.74B. The lowest valued company is NMFC at 658.33M.

High and low price notable news

The average weekly price growth across all stocks in the Simplify VettaFi Private Credit Strategy ETF (PCR) ETF was -0%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was -4%. GOF experienced the highest price growth at 2%, while PSEC experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Simplify VettaFi Private Credit Strategy ETF (PCR) ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was -10% and the average quarterly volume growth was -12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 48
Price Growth Rating: 54
SMR Rating: 51
Profit Risk Rating: 70
Seasonality Score: 35 (-100 ... +100)
View a ticker or compare two or three
PCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Miscellaneous

Category
Nontraditional Bond
Address
Simplify Exchange Traded Funds154 W 14TH ST FLOOR 2
Phone
614-469-3294
Web
N/A
Momentum Indicator for PCR turns negative, indicating new downward trend